Abiopharma

New Form SCHEDULE 13D/A - INDIVIOR PLC Filed: 2025-09-05 AccNo: 0001011438-25-000461 Size: 30 KB

New Form 144 - Perimeter Solutions, Inc. Filed: 2025-09-05 AccNo: 0001950047-25-006785 Size: 5 KB

New Form 144 - U S PHYSICAL THERAPY INC /NV Filed: 2025-09-05 AccNo: 0001950047-25-006784 Size: 4 KB

New Form 8-K - Ocugen, Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087801 Size: 199 KB Item 1.01: Entry into a Material Definitive Agreement

New Form 424B5 - Ainos, Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012728 Size: 29 KB

New Form 8-K - Mersana Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087800 Size: 190 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form S-8 POS - STAR OPERATING COMPANIES, INC. Filed: 2025-09-05 AccNo: 0001193125-25-197223 Size: 28 KB

Kaye Edward M. MD 🔴 sold 322.5K shares (2 derivative) of Stoke Therapeutics, Inc. (STOK) at $8.33 ($1.5M) Transaction Date: Sep 04, 2025 | Filing ID: 023792

New Form 144 - HEALTHEQUITY, INC. Filed: 2025-09-05 AccNo: 0001950047-25-006781 Size: 4 KB

New Form POS AM - STAR OPERATING COMPANIES, INC. Filed: 2025-09-05 AccNo: 0001193125-25-197218 Size: 22 KB